Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children

American Heart Journal

Volumn 139, Issue 2, 2000, Pages S96-S106

  Pierpont, Mary Ella M ^a   Breningstall, Galen N ^b   Stanley, Charles A ^c   Singh, Amarjit ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CARRIER PROTEIN;

CARDIOMEGALY; CARDIOMYOPATHY; CARNITINE DEFICIENCY; CASE REPORT; CHILD; COMA; CONFERENCE PAPER; FAMILIAL DISEASE; FATTY ACID TRANSPORT; FEMALE; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; MALE; MUSCLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; SIBLING;

BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; BIOPSY; CARDIOMYOPATHY, DILATED; CARNITINE; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; FIBROBLASTS; HUMANS; INFANT; KIDNEY TUBULES; MALE; MUSCLE, SKELETAL; MYOCARDIUM; NUCLEAR FAMILY; ORGANIC CATION TRANSPORT PROTEINS; RADIOGRAPHY, THORACIC;

EID: 0033954046     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.103921     Document Type: Article

References (35)

1. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1994;330:913-9.
2. Winter SC, Jue K, Prochazka J, Francis P, Hamilton W, Linn L, et al. The role of L-carnitine in pediatric cardiomyopathy. J Child Neurol 1995;10 Suppl 2:S45-2S51.
3. Bremer J. Carnitine-metabolism and functions. Physiol Rev 1983;63:1420-80.
4. Treem WR, Stanley CA, Finegold DA, Hale DE, Coates PM. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med 1988;319: 1331-6.
5. Eriksson BO, Lindstedt S, Nordin I. Hereditary defect in carnitine transport is expressed in skin fibroblasts. Pediatr Res 1990;28: 247-55.
6. Tein I, DeVivo DC, Bierman F, Pulver P, DeMierleir LJ, Cvitanovic-Sojat L, et al. Impaired skin fibroblasts carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitineresponsive cardiomyopathy. Pediatr Res 1990;28:247-55.
7. Stanley CA, DeLeeuw S, Coates PM, Viany-Liaud C, Divry P, Bonnefont JP, et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 1991;30:709-16.
8. Breningstall GN. Carnitine deficiency syndromes. Pediatr Neurol 1990;6:75-81.
9. Scaglia F, Wang Y, Singh RH, Dembure PP, Pasquali M, Fernhoff PM, et al. Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency. Genet Med 1998;1:34-9.
10. Silverman NH. Pediatric echocardiography. Baltimore: Williams & Wilkins; 1993.
11. +-ATPase by palmityl carnitine and palmityl CoA. Biochim Biophys Res Commun 1977;74:677-84.
12. Chapoy PR, Angelini C, Brown WJ, Stiff JE, Shug AL, Cederbaum SD. Systemic carnitine deficiency: a treatable inherited lipid storage disease presenting as Reye's syndrome. N Engl J Med 1980; 303:1389-94.
13. Morand P, Despert F, Carrier HN, Sudubray BM, Fardeau M, Romieux B, et al. Myopathie lipidique avec cardiomyopathie severe par deficit generalise en carnitine. Arch Mal Coeur 1979;5: 536-44.
14. Tripp ME, Katcher ML, Peters HA, Gilbert EF, Arya S, Hodach RJ, et al. Systemic carnitine deficiency presenting as familial fibroelastosis: a treatable cardiomyopathy. N Engl J Med 1981;305:385-90.
15. Waber LJ, Valle D, Neill C, Di Mauro S, Shug A. Carnitine deficiency presenting as familial cardiomyopathy, a treatable defect in carnitine transport. J Pediatr 1982;101:70-5.
16. Sansaricq CM, Rutkowski SF, Snyderman F, et al. Reye-like syndrome in a young girl with carnitine spillage [abstract]. Fed Proc 1987;46:1341.
17. Rodrigues-Pereira R, Scholte HR, Luyt-Houwen IEM, Vaandrager-Verduin MHM. Cardiomyopathy associated with carnitine loss in kidney and small intestine. Eur J Pediatr 1988;148:193-7.
18. Garavaglia MS, Uziel G, Dworzak F, Carrara F, DiDonato S. Primary carnitine deficiency: heterozygote and intrafamilial phenotypic variation. Neurology 1991;41:1691-3.
19. Christensen E, Vikre-Jorgensen J. Six years' experience with carnitine supplementation in a patient with an inherited defective carnitine transport system. J Inherit Metab Dis 1995;18:233-6.
20. Briones P, Garavaglia B, Ribes A, Yoldi ME, Rodes M, Romen C, et al. Clinical and biochemical findings in a Spanish boy with primary carnitine deficiency. J Inherit Metab Dis 1995;18:237-40.
21. Bennett MJ, Hall DE, Pottlitt RJ, Stanley CA, Variend S. Endocardial fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transporter. Clin Cardiol 1996; 19:243-6.
22. Rinaldo P, Stanley CA, Hsu BYL, Sabchez LA, Stern HJ. Sudden neonatal death in carnitine transporter deficiency. J Pediatr 1997;131:304-5.
23. Pons R, Carrozzo R, Tein I, Walker WF, Addonizo LJ, Takahashi T, et al. Deficient muscle carnitine transport in primary carnitine deficiency. Pediatr Res 1997;42:583-7.
24. Shoji Y, Koizumi A, Kayo T, Korson MS, Perez-Atayde A, Lacro RV, et al. Evidence for linkage of human primary systemic carnitine deficiency with D5S436: a novel gene locus on chromosome 5q. Am J Hum Genet 1998;63:101-8.
25. Schwartz ML, Cox GF, Lin AE, Fisher LD, Gersh BJ, Tajik AJ, et al. Clinical approach to genetic cardiomyopathy in children. Circulation 1996;94:2021-38.
26. Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ, et al. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol 1985;6:1126-31.
27. Taliercio CP. Dilated cardiomyopathy in children. J Am Coll Cardiol 1988;11:145-6.
28. Griffin ML, Hernandez A, Martin TC, Goldring D, Bolman RM, Spray TL, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 1988;11:139-44.
29. Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 1991;68:365-9.
30. Friedman RA, Moak JP, Garson A. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 1991;18:152-6.
31. Chen SC, Nouri S, Balfour I, Jureidini S, Appleton RS. Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol 1990;15:189-93.
32. Kaido M, Fujimura H, Ono A, Toyooka K, Yoshikawa H, Nishinura T, et al. Mitochondrial abnormalities in a murine model of primary carnitine deficiency. Eur Neurol 1997;38:302-9.
33. Hashimoto N, Suzuki F, Tamai I, Nikaido H, Kuwajima M, Hayakawa J, et al. Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transporter deficiency. Biochem Pharmacol 1998;55:1729-32.
34. Lamhonwah AM, Tein I. Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transport gene. Biochem Biophys Res Commun 1998;252:396-401.
35. Wang Y, Ye J, Ganapathy V, Longo N. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. Proc Natl Acad Sci USA 1999;96:2356-60.